Ortho-Preferred

Tranylcypromine/Parnate




Tranylcypromine is a non-hydrazine MAOI.
- usual effective dose of tranylcypromine is 30 mg/day, usually given in divided doses.  maximum dose of 60 mg/day, in divided doses.
- effects of tranylcypromine are observed after 10 days of treatment;
- monoamine oxidase inhibitory effects may be observed for 3 to 10 days after administration is discontinued;
- tranylcypromine must be used cautiously in patients receiving Tricyclics or other MAOI therapy



Original Text by Clifford R. Wheeless, III, MD.

Last updated by Data Trace Staff on Monday, July 30, 2012 4:08 pm